Histology
Basal Cell Carcinoma
CI-CAN-00000479Explore in graph →
57 active trials4 approved drugs6 evidence items
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00000479Explore in graph →
Clinical trials
361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (25)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00218868 | Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear | completed | — | 66 | Norwegian University of Science and TechnologyOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT05077033 | Intratumoral phIL12 GET(SmartGeneH&N) | completed | Phase 1 | 9 | Institute of Oncology LjubljanaOTHER | 1 | Dec 14, 2023 |
| clinicaltrials |
| NCT00314756 | Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage | completed | Phase 4 | 15 | Wake Forest UniversityOTHER | 1 | Aug 22, 2023 | clinicaltrials |
| NCT05126173 | DERM US and EU Validation Study | completed | — | 1,111 | Skin Analytics LimitedINDUSTRY | 2 | Jun 28, 2023 | clinicaltrials |
| NCT05853315 | BCC Excision Revisited | completed | — | 451 | Medical University of ViennaOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT04918381 | CellFX Treat & Resect Low-Risk BCC Feasibility Study | completed | N/A | 30 | Pulse Biosciences, Inc.INDUSTRY | 1 | Jan 11, 2023 | clinicaltrials |
| NCT00473343 | Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma | completed | Phase 3 | 102 | Galderma R&DINDUSTRY | 1 | Jan 5, 2023 | clinicaltrials |
| NCT01016899 | Electronic Brachytherapy for the Treatment of NMSC | completed | — | 187 | Xoft, Inc.INDUSTRY | 1 | Dec 13, 2022 | clinicaltrials |
| NCT04936932 | Laser Treatment of Basal Cell Carcinoma | completed | N/A | 3 | ScitonINDUSTRY | 1 | Dec 8, 2022 | clinicaltrials |
| NCT03517488 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors(DUET-2) | completed | Phase 1 | 150 | Xencor, Inc.INDUSTRY | 1 | Dec 1, 2022 | clinicaltrials |
| NCT05628714 | A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma | completed | — | 222 | Maastricht University Medical CenterOTHER | 1 | Nov 29, 2022 | clinicaltrials |
| NCT02144077 | Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy | completed | Phase 3 | 281 | Biofrontera Bioscience GmbHINDUSTRY | 1 | Nov 3, 2022 | clinicaltrials |
| NCT00540566 | Optical Biopsy of Human Skin in Conjunction With Laser Treatment | completed | — | 113 | University of California, IrvineOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05581342 | Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment(TOBI) | completed | N/A | 100 | Maastricht University Medical CenterOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT00470496 | Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer | completed | Phase 1 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT03541252 | Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study | completed | Phase 1 / Phase 2 | 20 | Merete HaedersdalOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03458117 | T-VEC in Non-melanoma Skin Cancer(20139157 T-VEC) | completed | Phase 1 | 26 | University of ZurichOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT00189280 | Aldara for the Treatment of Large and/or Multiple sBCC | completed | Phase 3 | 111 | MEDA Pharma GmbH & Co. KGINDUSTRY | 1 | Feb 22, 2022 | clinicaltrials |
| NCT03035188 | Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma(NICCI) | completed | Phase 2 | 40 | SRH Wald-Klinikum Gera GmbHOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT00189241 | A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma | completed | Phase 3 | 160 | MEDA Pharma GmbH & Co. KGINDUSTRY | 1 | Feb 7, 2022 | clinicaltrials |
| NCT00793169 | Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery | completed | — | 19 | Northwestern UniversityOTHER | 1 | Dec 6, 2021 | clinicaltrials |
| NCT00882791 | Basal Cell Carcinoma Recurrence After Mohs Surgery | completed | — | 115 | Northwestern UniversityOTHER | 1 | Dec 2, 2021 | clinicaltrials |
| NCT04279535 | Topical Vitamin C for Treatment of Basal Cell Cancer | completed | Early Phase 1 | 25 | Center for Biomedical Research, Inc.INDUSTRY | 1 | Nov 2, 2021 | clinicaltrials |
| NCT02436408 | VISmodegib for ORbital and Periocular Basal Cell Carcinoma(VISORB) | completed | Phase 4 | 35 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT03167762 | Photographing the Skin During Photodynamic Therapy | completed | N/A | 18 | University of DundeeOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT00847912 | CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial(VAKCCT) | completed | Phase 4 | 954 | VA Office of Research and DevelopmentFED | 1 | Jun 11, 2021 | clinicaltrials |
| NCT03180528 | Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer | completed | Phase 2 | 30 | Kavita SarinOTHER | 1 | Jun 8, 2021 | clinicaltrials |
| NCT02781389 | Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions(JONAS) | completed | — | 53 | University Hospital, EssenOTHER | 1 | Jun 3, 2021 | clinicaltrials |
| NCT01835626 | Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma | completed | Phase 2 | 24 | Sue YomOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT04795297 | Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation | completed | — | 804 | University Hospital, MontpellierOTHER | 1 | Mar 12, 2021 | clinicaltrials |
| NCT00880308 | Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors | completed | Phase 1 | 103 | Novartis PharmaceuticalsINDUSTRY | 4 | Dec 19, 2020 | clinicaltrials |
| NCT01208831 | An East Asian Study of LDE225 | completed | Phase 1 | 45 | Novartis PharmaceuticalsINDUSTRY | 3 | Dec 19, 2020 | clinicaltrials |
| NCT02580916 | Utility of the Skin Cancer Quality of Life Impact Tool(SCQOLIT) | completed | N/A | 318 | Oxford University Hospitals NHS TrustOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT02120677 | Topical Itraconazole in the Treatment of Basal Cell Carcinoma | completed | Early Phase 1 | 5 | Johns Hopkins UniversityOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT02825511 | Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma(CAC-CBC) | completed | — | 2,738 | University Hospital, BordeauxOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT02371967 | A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC)(ROSETT) | completed | — | 50 | Hoffmann-La RocheINDUSTRY | 1 | Oct 9, 2020 | clinicaltrials |
| NCT03331874 | RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma(RCM-1) | completed | — | 352 | Julie DawsonOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03714529 | A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma | completed | Phase 2 | 10 | Herlev and Gentofte HospitalOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT02354261 | Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) | completed | Phase 2 | 38 | HedgePath Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 5, 2020 | clinicaltrials |
| NCT02310503 | Spanish Registry of Mohs Surgery(REGESMOHS) | completed | — | 6,000 | Fundación Academia Española de DermatologíaOTHER | 1 | May 5, 2020 | clinicaltrials |
| NCT01872130 | Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins | completed | — | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 1, 2020 | clinicaltrials |
| NCT00005884 | Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer | completed | Phase 3 | — | University of Wisconsin, MadisonOTHER | 0 | Dec 13, 2019 | clinicaltrials |
| NCT03610620 | Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery(FCM-P) | completed | N/A | 30 | Julie DawsonOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT02623101 | Reflectance Confocal Microscopy in Basal Cell Carcinoma | completed | N/A | 288 | Radboud University Medical CenterOTHER | 1 | Sep 20, 2019 | clinicaltrials |
| NCT01245972 | Pilot Study of PDL to Treat BCC and SCCIS(PDLNMSC) | completed | N/A | 23 | University of California, San DiegoOTHER | 0 | Sep 16, 2019 | clinicaltrials |
| NCT02662244 | Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma | completed | N/A | 33 | University of California, San DiegoOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT01327053 | A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma(BOLT) | completed | Phase 2 | 230 | Novartis PharmaceuticalsINDUSTRY | 12 | Aug 28, 2019 | clinicaltrials |
| NCT01540695 | Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology | completed | — | 180 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 31, 2019 | clinicaltrials |
| NCT03237013 | Strategies to Promote Skin Health | completed | N/A | 219 | San Diego State UniversityOTHER | 1 | Jul 5, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Dec 29, 2023source: clinicaltrials